Kineta, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

49461C102
SEDOL

N/A
CIK

0001445283

kinetabio.com
LEI:
FIGI: BBG001CPMPK6
KANT

Kineta, Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
AI
PROFILER
NAME
Kineta, Inc.
ISIN
US49461C1027
TICKER
KANT
MIC
XOTC
REUTERS
KANT.PK
BLOOMBERG
KANT US
EN 728x90
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants

The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by PR-Newswire.

Thu, 12.12.2024       Kineta
US49461C1027

NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Kineta, Inc. (OTC: KANT), relating to the proposed merger with TuHURA Biosciences, Inc. Under the terms of the agreement, TuHURA would acquire the rights to Kineta's novel KVA12123 antibody for a combination of cash and shares of TuHURA common stock.

We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S